The role of secretory phospholipase A2 in the central nervous system and neurological diseases

Molecular Neurobiology

Volumn 49, Issue 2, 2014, Pages 863-876

  Yagami, Tatsurou ^a   Yamamoto, Yasuhiro ^a   Koma, Hiromi ^a  

^a HIMEJI DOKKYO UNIVERSITY   (Japan)

Author keywords

Alzheimer's disease; Cerebrovascular disease; Long term potentiation; Neuronal apoptosis

Indexed keywords

AMMODYTOXIN C; AMYLOID BETA PROTEIN; BROMOENOL LACTONE; CALCIUM; CALCIUM CHANNEL L TYPE; CARBACHOL; COMPLEMENTARY DNA; ESTERASE; ESTERASE INHIBITOR; INDOXAM; MESSENGER RNA; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PENTETRAZOLE; PHOSPHOLIPASE A2; PHOSPHOLIPASE A2 INHIBITOR; PHOSPHOLIPASE A2 RECEPTOR; POTASSIUM; SECRETORY PHOSPHOLIPASE A2; SECRETORY PHOSPHOLIPASE A2 IB; SECRETORY PHOSPHOLIPASE A2 IIA; SECRETORY PHOSPHOLIPASE A2 IIC; SECRETORY PHOSPHOLIPASE A2 IIE; SECRETORY PHOSPHOLIPASE A2 IIF; SECRETORY PHOSPHOLIPASE A2 III; SECRETORY PHOSPHOLIPASE A2 V; SECRETORY PHOSPHOLIPASE A2 X; SECRETORY PHOSPHOLIPASE A2 XII; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST; UNCLASSIFIED DRUG; UNINDEXED DRUG; VIPER VENOM;

ALZHEIMER DISEASE; ANTIGENICITY; APOPTOSIS; BRAIN CORTEX; BRAIN SYNAPTOSOME; CALCIUM SIGNALING; CELL DEATH; CENTRAL NERVOUS SYSTEM; CEREBROVASCULAR DISEASE; CORPUS STRIATUM; CYTOPLASM; ENZYME SPECIFICITY; EPILEPSY; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; HIPPOCAMPUS; HUMAN; HYPOTHALAMUS; LONG TERM POTENTIATION; MAMMAL; MESENCEPHALON; MULTIPLE SCLEROSIS; NERVE CELL; NERVE CELL NECROSIS; NERVOUS SYSTEM DEVELOPMENT; NEUROLOGIC DISEASE; NEUROPATHOLOGY; NEUROTRANSMISSION; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PATHOPHYSIOLOGY; PENTYLENETETRAZOLE-INDUCED SEIZURE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; RECEPTOR UPREGULATION; REVIEW; SPINAL CORD INJURY; SYNAPSE VESICLE; ANIMAL; ENZYMOLOGY; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; CENTRAL NERVOUS SYSTEM; HUMANS; NERVOUS SYSTEM DISEASES; PHOSPHOLIPASES A2, SECRETORY; SIGNAL TRANSDUCTION;

EID: 84896522235     PISSN: 08937648     EISSN: 15591182     Source Type: Journal    
DOI: 10.1007/s12035-013-8565-9     Document Type: Review

References (107)

1. Goracci G, Ferrini M, Nardicchi V (2010) Low molecular weight phospholipases A2 in mammalian brain and neural cells: roles in functions and dysfunctions. Mol Neurobiol 41(2-3):274-289
2. Farooqui AA, Ong WY, Horrocks LA (2006) Inhibitors of brain phospholipase A2 activity: their neuropharmacological effects and therapeutic importance for the treatment of neurologic disorders. Pharmacol Rev 58(3):591-620 (Pubitemid 44403685)
3. Laychock SG (1982) Phospholipase A2 activity in pancreatic islets is calcium-dependent and stimulated by glucose. Cell Calcium 3(1):43-54
4. Clapham DE (1995) Calcium signaling. Cell 80(2):259-268
5. Rosa AO, Rapoport SI (2009) Intracellular- and extracellular-derived Ca(2+) influence phospholipase A(2)-mediated fatty acid release from brain phospholipids. Biochim Biophys Acta 1791(8):697-705
6. Grataroli R, De Caro A, Guy O, Amic J, Figarella C (1981) Isolation and properties of prophospholipase A2 from human pancreatic juice. Biochimie 63(8-9):677-684 (Pubitemid 12241887)
7. Kolko M, Christoffersen NR, Varoqui H, Bazan NG (2005) Expression and induction of secretory phospholipase A2 group IB in brain. Cell Mol Neurobiol 25(7):1107-1122 (Pubitemid 43042779)
8. Suzuki N, Ishizaki J, Yokota Y, Higashino K, Ono T, Ikeda M, Fujii N, Kawamoto K, Hanasaki K (2000) Structures, enzymatic properties, and expression of novel human and mouse secretory phospholipase A(2)s. J Biol Chem 275(8):5785-5793 (Pubitemid 30115223)
9. Molloy GY, Rattray M, Williams RJ (1998) Genes encoding multiple forms of phospholipase A2 are expressed in rat brain. Neurosci Lett 258(3):139-142 (Pubitemid 29023567)
10. Valentin E, Koduri RS, Scimeca JC, Carle G, Gelb MH, Lazdunski M, Lambeau G (1999) Cloning and recombinant expression of a novel mouse-secreted phospholipase A2. J Biol Chem 274(27):19152-19160
11. Kolko M, Christoffersen NR, Barreiro SG, Miller ML, Pizza AJ, Bazan NG (2006) Characterization and location of secretory phospholipase A2 groups IIE, V, and X in the rat brain. J Neurosci Res 83(5):874-882
12. Valentin E, Singer AG, Ghomashchi F, Lazdunski M, Gelb MH, Lambeau G (2000) Cloning and recombinant expression of human group IIF-secreted phospholipase A(2). Biochem Biophys Res Commun 279(1):223-228
13. Valentin E, Ghomashchi F, Gelb MH, Lazdunski M, Lambeau G (2000) Novel human secreted phospholipase A(2) with homology to the group III bee venom enzyme. J Biol Chem 275(11):7492-7496 (Pubitemid 30159644)
14. Masuda S, Yamamoto K, Hirabayashi T, Ishikawa Y, Ishii T, Kudo I, Murakami M (2008) Human group III secreted phospholipase A2 promotes neuronal outgrowth and survival. Biochem J 409(2):429-438 (Pubitemid 351184961)
15. Chen J, Engle SJ, Seilhamer JJ, Tischfield JA (1994) Cloning and recombinant expression of a novel human low molecular weight Ca(2+)-dependent phospholipase A2. J Biol Chem 269(4):2365-2368
16. Shirai Y, Ito M (2004) Specific differential expression of phospholipase A2 subtypes in rat cerebellum. J Neurocytol 33(3):297-307 (Pubitemid 39361298)
17. Nardicchi V, Macchioni L, Ferrini M, Goracci G (2007) The presence of a secretory phospholipase A2 in the nuclei of neuronal and glial cells of rat brain cortex. Biochim Biophys Acta 1771(11):1345-1352 (Pubitemid 350217092)
18. Cupillard L, Koumanov K, Mattei MG, Lazdunski M, Lambeau G (1997) Cloning, chromosomal mapping, and expression of a novel human secretory phospholipase A2. J Biol Chem 272(25):15745-15752 (Pubitemid 27265549)
19. Gelb MH, Valentin E, Ghomashchi F, Lazdunski M, Lambeau G (2000) Cloning and recombinant expression of a structurally novel human secreted phospholipase A2. J Biol Chem 275(51):39823-39826 (Pubitemid 32064600)
20. Negre-Aminou P, Nemenoff RA, Wood MR, de la Houssaye BA, Pfenninger KH (1996) Characterization of phospholipase A2 activity enriched in the nerve growth cone. J Neurochem 67(6):2599-2608 (Pubitemid 26392533)
21. Nakashima S, Kitamoto K, Arioka M (2004) The catalytic activity, but not receptor binding, of sPLA2s plays a critical role for neurite outgrowth induction in PC12 cells. Brain Res 1015(1-2):207-211 (Pubitemid 38829759)
22. Ikeno Y, Konno N, Cheon SH, Bolchi A, Ottonello S, Kitamoto K, Arioka M (2005) Secretory phospholipases A2 induce neurite out-growth in PC12 cells through lysophosphatidylcholine generation and activation of G2A receptor. J Biol Chem 280(30):28044-28052 (Pubitemid 41076922)
23. Forlenza OV, Mendes CT, Marie SK, Gattaz WF (2007) Inhibition of phospholipase A2 reduces neurite outgrowth and neuronal viability. Prostaglandins Leukot Essent Fatty Acids 76(1):47-55 (Pubitemid 46038720)
24. DeCoster MA (2003) Group III secreted phospholipase A2 causes apoptosis in rat primary cortical neuronal cultures. Brain Res 988(1-2):20-28 (Pubitemid 37289491)
25. Makarova YV, Osipov AV, Tsetlin VI, Utkin YN (2006) Influence of phospholipases A2 from snake venoms on survival and neurite outgrowth in pheochromocytoma cell line PC12. Biochemistry (Mosc) 71(6):678-684 (Pubitemid 43937044)
26. Yagami T, Yamamoto Y, Koma H, Nakamura T, Takasu N, Okamura N (2013) L-type voltage-dependent calcium channel is involved in the snake venom group IA secretory phospholipase A2-induced neuronal apoptosis. Neurotoxicology 35:146-153
27. Yagami T, Ueda K, Asakura K, Hata S, Kuroda T, Sakaeda T, Kishino J, Sakaguchi G, Itoh N, Hori Y (2002) Group IB secretory phospholipase A(2)induces cell death in the cultured cortical neurons: a possible involvement of its binding sites. Brain Res 949(1-2):197-201 (Pubitemid 35246193)
28. Yagami T, Ueda K, Asakura K, Hata S, Kuroda T, Sakaeda T, Takasu N, Tanaka K, Gemba T, Hori Y (2002) Human group IIA secretory phospholipase A2 induces neuronal cell death via apoptosis. Mol Pharmacol 61(1):114-126 (Pubitemid 34049518)
29. Matsuzawa A, Murakami M, Atsumi G, Imai K, Prados P, Inoue K, Kudo I (1996) Release of secretory phospholipase A2 from rat neuronal cells and its possible function in the regulation of catecholamine secretion. Biochem J 318(Pt 2):701-709 (Pubitemid 26305977)
30. Yang H, Siddiqi NJ, Alhomida AS, Ong WY (2013) Expression and localization of sPLA2-III in the rat CNS. Neurochem Res 38(4):753-760
31. Kim DK, Rordorf G, Nemenoff RA, Koroshetz WJ, Bonventre JV (1995) Glutamate stably enhances the activity of two cytosolic forms of phospholipase A2 in brain cortical cultures. Biochem J 310(Pt 1):83-90
32. DeCoster MA, Lambeau G, Lazdunski M, Bazan NG (2002) Secreted phospholipase A2 potentiates glutamate-induced calcium increase and cell death in primary neuronal cultures. J Neurosci Res 67(5):634-645 (Pubitemid 34202799)
33. Kolko M, DeCoster MA, de Turco EB, Bazan NG (1996) Synergy by secretory phospholipase A2 and glutamate on inducing cell death and sustained arachidonic acid metabolic changes in primary cortical neuronal cultures. J Biol Chem 271(51):32722-32728 (Pubitemid 27008697)
34. Rodriguez De Turco EB, Jackson FR, DeCoster MA, Kolko M, Bazan NG (2002) Glutamate signalling and secretory phospholipase A2 modulate the release of arachidonic acid from neuronal membranes. J Neurosci Res 68(5):558-567
35. Wolf MJ, Izumi Y, Zorumski CF, Gross RW (1995) Long-term potentiation requires activation of calcium-independent phospholipase A2. FEBS Lett 377(3):358-362 (Pubitemid 26027153)
36. Malinow R, Schulman H, Tsien RW (1989) Inhibition of postsynaptic PKC or CaMKII blocks induction but not expression of LTP. Science 245(4920):862-866 (Pubitemid 19223665)
37. English JD, Sweatt JD (1997) A requirement for the mitogen-activated protein kinase cascade in hippocampal long term potentiation. J Biol Chem 272(31):19103-19106 (Pubitemid 27337694)
38. Massicotte G, Baudry M (1990) Modulation of DL-alpha-Amino-3-hydroxy-5- methylisoxazole-4-propionate (AMPA)/quisqualate receptors by phospholipase A2 treatment. Neurosci Lett 118(2):245-248 (Pubitemid 20334892)
39. Dumuis A, Sebben M, Haynes L, Pin JP, Bockaert J (1988) NMDA receptors activate the arachidonic acid cascade system in striatal neurons. Nature 336(6194):68-70 (Pubitemid 18262135)
40. Okada D, Yamagishi S, Sugiyama H (1989) Differential effects of phospholipase inhibitors in long-term potentiation in the rat hippocampal mossy fiber synapses and Schaffer/commissural synapses. Neurosci Lett 100(1-3):141-146 (Pubitemid 19128164)
41. Drapeau C, Pellerin L, Wolfe LS, Avoli M (1990) Long-term changes of synaptic transmission induced by arachidonic acid in the CA1 subfield of the rat hippocampus. Neurosci Lett 115(2-3):286-292 (Pubitemid 20231629)
42. Arai A, Lynch G (1992) Antagonists of the platelet-activating factor receptor block long-term potentiation in hippocampal slices. Eur J Neurosci 4(5):411-419
43. Wieraszko A, Li G, Kornecki E, Hogan MV, Ehrlich YH (1993) Long-term potentiation in the hippocampus induced by plateletactivating factor. Neuron 10(3):553-557 (Pubitemid 23111745)
44. Williams JH, Errington ML, Lynch MA, Bliss TV (1989) Arachidonic acid induces a long-term activity-dependent enhancement of synaptic transmission in the hippocampus. Nature 341(6244):739-742 (Pubitemid 19260887)
45. O'Dell TJ, Hawkins RD, Kandel ER, Arancio O (1991) Tests of the roles of two diffusible substances in long-term potentiation: evidence for nitric oxide as a possible early retrograde messenger. Proc Natl Acad Sci U S A 88(24):11285-11289 (Pubitemid 21916025)
46. Miller B, Sarantis M, Traynelis SF, Attwell D (1992) Potentiation of NMDA receptor currents by arachidonic acid. Nature 355(6362):722-725
47. Fujita S, Ikegaya Y, Nishikawa M, Nishiyama N, Matsuki N (2001) Docosahexaenoic acid improves long-term potentiation attenuated by phospholipase A(2) inhibitor in rat hippocampal slices. Br J Pharmacol 132(7):1417-1422 (Pubitemid 32281029)
48. Hadjiagapiou C, Spector AA (1987) Docosahexaenoic acid metabolism and effect on prostacyclin production in endothelial cells. Arch Biochem Biophys 253(1):1-12 (Pubitemid 17025209)
49. Praznikar ZJ, Kovacic L, Rowan EG, Romih R, Rusmini P, Poletti A, Krizaj I, Pungercar J (2008) A presynaptically toxic secreted phospholipase A2 is internalized intomotoneuron-like cells where it is rapidly translocated into the cytosol. Biochim Biophys Acta 1783(6):1129-1139
50. Wisniewski T, Frangione B (1996) Molecular biology of brain aging and neurodegenerative disorders. Acta Neurobiol Exp (Wars) 56(1):267-279 (Pubitemid 26126150)
51. Yagami T (2006) Cerebral arachidonate cascade in dementia: Alzheimer 's disease and vascular dementia. Curr Neuropharmacol 4(1):87-100
52. Lin TN, Wang Q, Simonyi A, Chen JJ, Cheung WM, He YY, Xu J, Sun AY, Hsu CY, Sun GY (2004) Induction of secretory phospholipase A2 in reactive astrocytes in response to transient focal cerebral ischemia in the rat brain. J Neurochem 90(3):637-645 (Pubitemid 38989394)
53. Moses GS, Jensen MD, Lue LF, Walker DG, Sun AY, Simonyi A, Sun GY (2006) Secretory PLA2-IIA: a new inflammatory factor for Alzheimer 's disease. J Neuroinflammation 3:28
54. Bezprozvanny I, Mattson MP (2008) Neuronal calcium mishandling and the pathogenesis of Alzheimer 's disease. Trends Neurosci 31(9):454-463
55. 2+ channels: a possible involvement of free radicals. J Neurochem 68(1):265-271
56. Mattson MP, Cheng B, Davis D, Bryant K, Lieberburg I, Rydel RE (1992) beta-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J Neurosci 12(2):376-389
57. Ueda K, Fukui Y, Kageyama H (1994) Amyloid beta protein-induced neuronal cell death: neurotoxic properties of aggregated amyloid beta protein. Brain Res 639(2):240-244 (Pubitemid 24078561)
58. 2+ channels in cultured rat cortical neurons. J Neurochem 85(3):749-758
59. Viola HM, Arthur PG, Hool LC (2007) Transient exposure to hydrogen peroxide causes an increase in mitochondria-derived superoxide as a result of sustained alteration in L-type Ca2+ channel function in the absence of apoptosis in ventricular myocytes. Circ Res 100(7):1036-1044 (Pubitemid 46598928)
60. Nunomura A, Perry G, Aliev G, Hirai K, Takeda A, Balraj EK, Jones PK, Ghanbari H, Wataya T, Shimohama S, Chiba S, Atwood CS, Petersen RB, Smith MA (2001) Oxidative damage is the earliest event in Alzheimer disease. J Neuropathol Exp Neurol 60(8):759-767 (Pubitemid 32678256)
61. Paola D, Domenicotti C, Nitti M, Vitali A, Borghi R, Cottalasso D, Zaccheo D, Odetti P, Strocchi P, Marinari UM, Tabaton M, Pronzato MA (2000) Oxidative stress induces increase in intracellular amyloid beta-protein production and selective activation of betaI and betaII PKCs in NT2 cells. Biochem Biophys Res Commun 268(2):642-646 (Pubitemid 30119675)
62. Harada J, Sugimoto M (1999) Activation of caspase-3 in beta-amyloid-induced apoptosis of cultured rat cortical neurons. Brain Res 842(2):311-323 (Pubitemid 29475165)
63. Lee C, Park DW, Lee J, Lee TI, Kim YJ, Lee YS, Baek SH (2006) Secretory phospholipase A2 induces apoptosis through TNF-alpha and cytochrome c -mediated caspase cascade in murine macrophage RAW 264.7 cells. Eur J Pharmacol 536(1-2):47-53
64. Black SE (2005) Vascular dementia. Stroke risk and sequelae define therapeutic approaches. Postgrad Med 117(1):15-16, 19-25
65. in't Veld BA, Ruitenberg A, Hofman A, Stricker BH, Breteler MM (2001) Antihypertensive drugs and incidence of dementia: the Rotterdam Study. Neurobiol Aging 22(3):407-412
66. Schehr RS (1996) New treatments for acute stroke. Nat Biotechnol 14(11):1549-1554
67. Umemura K, Kawai H, Ishihara H, Nakashima M (1995) Inhibitory effect of clopidogrel, vapiprost and argatroban on the middle cerebral artery thrombosis in the rat. Jpn J Pharmacol 67(3):253-258
68. Hallenbeck JM (1994) Blood-damaged tissue interaction in experimental brain ischemia. Acta Neurochir Suppl (Wien) 60:233-237
69. Li Y, Sharov VG, Jiang N, Zaloga C, Sabbah HN, Chopp M (1995) Ultrastructural and light microscopic evidence of apoptosis after middle cerebral artery occlusion in the rat. Am J Pathol 146(5):1045-1051
70. Yagami T, Ueda K, Asakura K, Hayasaki-Kajiwara Y, Nakazato H, Sakaeda T, Hata S, Kuroda T, Takasu N, Hori Y (2002) Group IB secretory phospholipase A2 induces neuronal cell death via apoptosis. J Neurochem 81(3):449-461 (Pubitemid 34809324)
71. 2+ channels. Brain Res 960(1-2):71-80
72. Prat A, Antel J (2005) Pathogenesis ofmultiple sclerosis. Curr Opin Neurol 18(3):225-230
73. Pinto F, Brenner T, Dan P, Krimsky M, Yedgar S (2003) Extracellular phospholipase A2 inhibitors suppress central nervous system inflammation. Glia 44(3):275-282 (Pubitemid 37484478)
74. Cunningham TJ, Yao L, Oetinger M, Cort L, Blankenhorn EP, Greenstein JI (2006) Secreted phospholipase A2 activity in experimental autoimmune encephalomyelitis and multiple sclerosis. J Neuroinflammation 3:26
75. Profyris C, Cheema SS, Zang D, Azari MF, Boyle K, Petratos S (2004) Degenerative and regenerativemechanisms governing spinal cord injury. Neurobiol Dis 15(3):415-436 (Pubitemid 38429958)
76. Titsworth WL, Cheng X, Ke Y, Deng L, Burckardt KA, Pendleton C, Liu NK, Shao H, Cao QL, Xu XM (2009) Differential expression of sPLA2 following spinal cord injury and a functional role for sPLA2-IIA in mediating oligodendrocyte death. Glia 57(14):1521-1537
77. Yegin A, Akbas SH, Ozben T, Korgun DK (2002) Secretory phospholipase A2 and phospholipids in neural membranes in an experimental epilepsy model. Acta Neurol Scand 106(5):258-262 (Pubitemid 35177992)
78. Visioli F, Rodriguez de Turco EB, Kreisman NR, Bazan NG (1994) Membrane lipid degradation is related to interictal cortical activity in a series of seizures. Metab Brain Dis 9(2):161-170 (Pubitemid 24209704)
79. Lambeau G, Ancian P, Barhanin J, Lazdunski M (1994) Cloning and expression of a membrane receptor for secretory phospholipases A2. J Biol Chem 269(3):1575-1578 (Pubitemid 24035339)
80. Lambeau G, Barhanin J, Schweitz H, Qar J, Lazdunski M (1989) Identification and properties of very high affinity brain membrane-binding sites for a neurotoxic phospholipase from the Taipan venom. J Biol Chem 264(19):11503-11510 (Pubitemid 19168891)
81. Copic A, Vucemilo N, Gubensek F, Krizaj I (1999) Identification and purification of a novel receptor for secretory phospholipase A(2) in porcine cerebral cortex. J Biol Chem 274(37):26315-26320
82. 125I-labelled pancreatic secretory phospholipase A2 in rat brain. Brain Res Mol Brain Res 49(1-2):120-126
83. Higashino K, Ishizaki J, Kishino J, Ohara O, Arita H (1994) Structural comparison of phospholipase-A2-binding regions in phospholipase-A2 receptors fromvarious mammals. Eur J Biochem 225(1):375-382
84. Nakajima M, Hanasaki K, Ueda M, Arita H (1992) Effect of pancreatic type phospholipase A2 on isolated porcine cerebral arteries via its specific binding sites. FEBS Lett 309(3):261-264
85. Kishino J, Ohara O, Nomura K, Kramer RM, Arita H (1994) Pancreatic-type phospholipase A2 induces group II phospholipase A2 expression and prostaglandin biosynthesis in ratmesangial cells. J Biol Chem 269(7):5092-5098
86. Arita H, Hanasaki K, Nakano T, Oka S, Teraoka H, Matsumoto K (1991) Novel proliferative effect of phospholipase A2 in Swiss 3T3 cells via specific binding site. J Biol Chem 266(29):19139-19141 (Pubitemid 21908205)
87. Hanasaki K, Arita H (1992) Characterization of a high affinity binding site for pancreatic-type phospholipase A2 in the rat. Its cellular and tissue distribution. J Biol Chem 267(9):6414-6420
88. Ishizaki J, Hanasaki K, Higashino K, Kishino J, Kikuchi N, Ohara O, Arita H (1994) Molecular cloning of pancreatic group I phospholipase A2 receptor. J Biol Chem 269(8):5897-5904 (Pubitemid 24242968)
89. Yokota Y, Hanasaki K, Ono T, Nakazato H, Kobayashi T, Arita H (1999) Suppression of murine endotoxic shock by sPLA2 inhibitor, indoxam, through group IIA sPLA2-independent mechanisms. Biochim Biophys Acta 1438(2):213-222 (Pubitemid 29236127)
90. Kolko M, de Turco EB, Diemer NH, Bazan NG (2002) Secretory phospholipase A2-mediated neuronal cell death involves glutamate ionotropic receptors. Neuroreport 13(15):1963-1966
91. Ray SK, Banik NL (2003) Calpain and its involvement in the pathophysiology of CNS injuries and diseases: therapeutic potential of calpain inhibitors for prevention of neurodegeneration. Curr Drug Targets CNS Neurol Disord 2(3):173-189
92. Sorce S, Krause KH (2009) NOX enzymes in the central nervous system: from signaling to disease. Antioxid Redox Signal 11(10):2481-2504
93. Bey EA, Xu B, Bhattacharjee A, Oldfield CM, Zhao X, Li Q, Subbulakshmi V, Feldman GM, Wientjes FB, Cathcart MK (2004) Protein kinase C delta is required for p47phox phosphorylation and translocation in activated human monocytes. J Immunol 173(9):5730-5738 (Pubitemid 39392162)
94. Simonyi A, He Y, Sheng W, Sun AY, Wood WG, Weisman GA, Sun GY (2010) Targeting NADPH oxidase and phospholipases A2 in Alzheimer's disease. Mol Neurobiol 41(2-3):73-86
95. Brennan AM, Suh SW, Won SJ, Narasimhan P, Kauppinen TM, Lee H, Edling Y, Chan PH, Swanson RA (2009) NADPH oxidase is the primary source of superoxide induced by NMDA receptor activation. Nat Neurosci 12(7):857-863
96. Shelat PB, Chalimoniuk M, Wang JH, Strosznajder JB, Lee JC, Sun AY, Simonyi A, Sun GY (2008) Amyloid beta peptide and NMDA induce ROS from NADPH oxidase and AA release from cytosolic phospholipase A2 in cortical neurons. J Neurochem 106(1):45-55 (Pubitemid 351840199)
97. Sherry ST, Ward M, Sirotkin K (1999) dbSNP-database for single nucleotide polymorphisms and other classes of minor genetic variation. Genome Res 9(8):677-679 (Pubitemid 29412785)
98. Eckert GP, Schaeffer EL, Schmitt A, Maras A, Gattaz WF (2011) Increased brain membrane fluidity in schizophrenia. Pharmacopsychiatry 44(4):161-162
99. Schaeffer EL, Gattaz WF, Eckert GP (2012) Alterations of brain membranes in Sshizophrenia: impact of phospholipase A2. Curr Top Med Chem
100. Barbosa NR, Junqueira RM, Vallada HP, Gattaz WF (2007) Association between BanI genotype and increased phospholipase A2 activity in schizophrenia. Eur Arch Psychiatry Clin Neurosci 257(6):340-343 (Pubitemid 47476721)
101. Bate C, Reid S, Williams A (2004) Phospholipase A2 inhibitors or platelet-activating factor antagonists prevent prion replication. J Biol Chem 279(35):36405-36411 (Pubitemid 39128979)
102. Bate C, Tayebi M, Williams A (2008) Sequestration of free cholesterol in cell membranes by prions correlates with cytoplasmic phospholipase A2 activation. BMC Biol 6:8
103. Yoshino H, Tomiyama H, Tachibana N, Ogaki K, Li Y, Funayama M, Hashimoto T, Takashima S, Hattori N (2010) Phenotypic spectrum of patients with PLA2G6 mutation and PARK14-linked parkinsonism. Neurology 75(15):1356-1361
104. Klivenyi P, Beal MF, Ferrante RJ, Andreassen OA, Wermer M, Chin MR, Bonventre JV (1998) Mice deficient in group IV cytosolic phospholipase A2 are resistant to MPTP neurotoxicity. J Neurochem 71(6):2634-2637 (Pubitemid 28531277)
105. Tariq M, Khan HA, Al Moutaery K, Al Deeb S (2001) Protective effect of quinacrine on striatal dopamine levels in 6-OHDA and MPTP models of Parkinsonism in rodents. Brain Res Bull 54(1):77-82 (Pubitemid 32156918)
106. Pereira MP, Hurtado O, Cardenas A, Bosca L, Castillo J, Davalos A, Vivancos J, Serena J, Lorenzo P, Lizasoain I, Moro MA (2006) Rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2 cause potent neuroprotection after experimental stroke through noncompletely overlapping mechanisms. J Cereb Blood Flow Metab 26(2):218-229 (Pubitemid 43151578)
107. Yagami T, Ueda K, Asakura K, Takasu N, Sakaeda T, Itoh N, Sakaguchi G, Kishino J, Nakazato H, Katsuyama Y, Nagasaki T, Okamura N, Hori Y, Hanasaki K, Arimura A, Fujimoto M (2003) Novel binding sites of 15-deoxy-Delta12,14- prostaglandin J2 in plasma membranes from primary rat cortical neurons. Exp Cell Res 291(1):212-227 (Pubitemid 37345153)